The epidemiology of multiple sclerosis in three Australian cities: Perth, Newcastle and Hobart - PubMed (original) (raw)
. 1988 Feb:111 ( Pt 1):1-25.
doi: 10.1093/brain/111.1.1.
Affiliations
- PMID: 3365543
- DOI: 10.1093/brain/111.1.1
The epidemiology of multiple sclerosis in three Australian cities: Perth, Newcastle and Hobart
S R Hammond et al. Brain. 1988 Feb.
Abstract
An epidemiological survey of multiple sclerosis (MS) in three Australian cities, Perth, Newcastle and Hobart, was undertaken with its prevalence day being the national census day on June 30, 1981, exactly twenty years after a previous survey of the same cities. The relationship between increasing prevalence and increasing south latitude found in the 1961 survey was confirmed in this present study. Prevalence rates had increased significantly over the twenty years between the studies. Over the same time period incidence rates had also increased in Newcastle and Hobart but had remained essentially stable in Perth although these changes were not significant. The rise in prevalence was due to a combination of factors of differing importance in each city. These factors included better case ascertainment, increased recognition of the less severely disabled patient, increased survival time and differential immigration of a population at a higher risk of developing MS than the indigenous population. Finally, analysis of MS prevalence rates amongst migrant populations in Perth and Hobart suggested that either the risk of acquisition of MS may extend over a wider age range than is generally accepted or that environmental factors prevalent in the former city have modified disease expression there.
Similar articles
- The epidemiology of multiple sclerosis in Queensland, Australia.
Hammond SR, de Wytt C, Maxwell IC, Landy PJ, English D, McLeod JG, McCall MG. Hammond SR, et al. J Neurol Sci. 1987 Sep;80(2-3):185-204. doi: 10.1016/0022-510x(87)90154-7. J Neurol Sci. 1987. PMID: 3681330 - The age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia.
Hammond SR, English DR, McLeod JG. Hammond SR, et al. Brain. 2000 May;123 ( Pt 5):968-74. doi: 10.1093/brain/123.5.968. Brain. 2000. PMID: 10775541 - Is it time for a new global classification of multiple sclerosis?
Melcon MO, Correale J, Melcon CM. Melcon MO, et al. J Neurol Sci. 2014 Sep 15;344(1-2):171-81. doi: 10.1016/j.jns.2014.06.051. Epub 2014 Jun 29. J Neurol Sci. 2014. PMID: 25062946 Review. - Descriptive epidemiology of multiple sclerosis in Europe in the 1980s: a critical overview.
Rosati G. Rosati G. Ann Neurol. 1994 Dec;36 Suppl 2:S164-74. doi: 10.1002/ana.410360803. Ann Neurol. 1994. PMID: 7998785 Review.
Cited by
- Vitamin D in Neurological Diseases.
Plantone D, Primiano G, Manco C, Locci S, Servidei S, De Stefano N. Plantone D, et al. Int J Mol Sci. 2022 Dec 21;24(1):87. doi: 10.3390/ijms24010087. Int J Mol Sci. 2022. PMID: 36613531 Free PMC article. Review. - NMOSD and MS prevalence in the Indigenous populations of Australia and New Zealand.
Bukhari W, Khalilidehkordi E, Mason DF, Barnett MH, Taylor BV, Fabis-Pedrini M, Kermode AG, Subramanian S, Waters P, Broadley SA; Australian and New Zealand NMO Collaboration. Bukhari W, et al. J Neurol. 2022 Feb;269(2):836-845. doi: 10.1007/s00415-021-10665-9. Epub 2021 Jul 2. J Neurol. 2022. PMID: 34213614 - Changing epidemiology of immune-mediated inflammatory diseases in immigrants: A systematic review of population-based studies.
Agrawal M, Shah S, Patel A, Pinotti R, Colombel JF, Burisch J. Agrawal M, et al. J Autoimmun. 2019 Dec;105:102303. doi: 10.1016/j.jaut.2019.07.002. Epub 2019 Jul 25. J Autoimmun. 2019. PMID: 31351784 Free PMC article. - Progressive Onset Multiple Sclerosis: Demographic, Clinical and Laboratory Characteristics of Patients With and Without Relapses in the Course.
Kaymakamzade B, Kiliç AK, Kurne AT, Karabudak R. Kaymakamzade B, et al. Noro Psikiyatr Ars. 2019 Mar;56(1):23-26. doi: 10.5152/npa.2017.19269. Epub 2018 Jul 4. Noro Psikiyatr Ars. 2019. PMID: 30911233 Free PMC article. - Non-pharmacological interventions for chronic pain in multiple sclerosis.
Amatya B, Young J, Khan F. Amatya B, et al. Cochrane Database Syst Rev. 2018 Dec 19;12(12):CD012622. doi: 10.1002/14651858.CD012622.pub2. Cochrane Database Syst Rev. 2018. PMID: 30567012 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical